2 Stocks Billionaires Can't Stop Buying

Multiple billionaire investors including Warren Buffett, Stanley Druckenmiller, Ken Fisher, and Ken Griffin have significantly increased their positions in Alphabet and Eli Lilly during Q2 2026. Alphabet is praised for its leadership in cloud computing, AI, and quantum computing, while Eli Lilly leads the obesity drug market and has strong positions in cancer, diabetes, and immunology. The article suggests both stocks are positioned to outperform the market long-term, though it cautions against blindly copying billionaire investment moves.